In our study , 1,099 men were randomly assigned in a 2:1 schedule to receive orteronel 400 mg plus prednisone 5 mg twice daily or placebo plus prednisone 5 mg twice daily , stratified by region ( Europe , North America [ NA ] , and non-Europe/NA ) and Brief Pain Inventory-Short Form worst pain score .